[HTML][HTML] Current status of cell-based therapies for COVID-19: evidence from mesenchymal stromal cells in sepsis and ARDS
Z Xu, Y Huang, J Zhou, X Deng, W He, X Liu… - Frontiers in …, 2021 - frontiersin.org
The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …
[HTML][HTML] Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS
Z Xu, Y Huang, J Zhou, X Deng, W He, X Liu… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …
[PDF][PDF] Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS
Z Xu, Y Huang, J Zhou, X Deng, W He… - Front. Immunol. 12 …, 2021 - scienceopen.com
The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …
Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
Z Xu, Y Huang, J Zhou, X Deng, W He, X Liu… - Frontiers in …, 2021 - europepmc.org
The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …
Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS
Z Xu, Y Huang, J Zhou, X Deng, W He… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …
Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS
Z Xu, Y Huang, J Zhou, X Deng, W He… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …